We are committed to serving the best interests of our shareholders.

<< Back
10/18/2018

TESARO to Announce Third-Quarter 2018 Financial Results on November 1, 2018

WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO) will announce third-quarter 2018 financial results on Thursday, November 1, 2018, after the close of the U.S. financial markets. TESARO’s senior management team will host a conference call and live audio webcast at 4:15 p.m. ET on November 1, 2018 to discuss the Company’s operating results for the quarter in greater detail, as well as the status of its development programs. 

This quarterly earnings call will be available via phone and webcast. The conference call dial-in information is listed below. To access the webcast, please log on to the TESARO website at www.tesarobio.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

******************CONFERENCE CALL & WEBCAST INFORMATION******************

TESARO will host a conference call and live audio webcast to discuss its third-quarter financial results.

WHEN: Thursday, November 1, 2018 at 4:15 p.m. ET
LIVE DOMESTIC & CANADA CALL-IN: (877) 853-5334
LIVE INTERNATIONAL CALL-IN: (970) 315-0307
THIS CALL WILL ALSO BE BROADCAST LIVE, LISTEN ONLY, VIA THE WEB AT: www.tesarobio.com

A replay will be available for 30 days at www.tesarobio.com.

**********************************************************************************

About TESARO

TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.

Investor/Media Contacts:

Kate Rausch
Director, Investor Relations
1.781-257-2505 or krausch@tesarobio.com

TESARO® logo_RGB_small.png

Source: TESARO, Inc.